Compositions for increasing energy in vivo

Patent 6159942 Issued on December 12, 2000. Estimated Expiration Date:

April 12, 2019. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Method for stimulating recovery from ischemia employing ribose and adenine
Patent #: 4605644
Issued on: 08/12/1986
Inventor: Foker

Method for stimulating recovery from ischemia
Patent #: 4719201
Issued on: 01/12/1988
Inventor: Foker

Method of determining the viability of tissue in an organism
Patent #: 4824660
Issued on: 04/25/1989
Inventor: Angello , et al.

Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
Patent #: 4871718
Issued on: 10/03/1989
Inventor: Carniglia

Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
Patent #: 4920098
Issued on: 04/24/1990
Inventor: Cotter, et al.

Method for treating vascular disease
Patent #: 4968719
Issued on: 11/06/1990
Inventor: Brevetti

Beverage compositions for human consumption
Patent #: 5114723
Issued on: 05/19/1992
Inventor: Stray-Gundersen

Improved sustained energy and anabolic composition and method of making
Patent #: 5292538
Issued on: 03/08/1994
Inventor: Paul, et al.

Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
Patent #: 5391550
Issued on: 02/21/1995
Inventor: Carniglia, et al.

Modulation of glycolytic ATP production
Patent #: 5707971
Issued on: 01/13/1998
Inventor: Fahy

More ...

Inventors

Application

No. 290789 filed on 04/12/1999

US Classes:

514/23Carbohydrate (i.e., saccharide radical containing) DOAI

Examiners

Primary: Reamer, James H.

Attorney, Agent or Firm

Schwegman, Lundberg, Woessner & Kluth, P.A.

Foreign Patent References

0312249 EP 04/13/1989
0573466 EP 12/13/1993
0680945 EP 11/13/1995
4228215 A1 DE 03/13/1994
94/02127 WO 02/13/1994
96/18313 WO 06/13/1996

International Class

A61K 031/70

Abstract

Precursors of adenosine triphosphate are administered orally to increase intracellular ATP concentration as dietary supplements or for treatment of reduced energy availability resulting from strenuous physical activity, illness or trauma. Pentose sugars are administered individually, mixed into dry food or in solution. The preferred pentose is D-ribose, singly or combined with creatine, pyruvate, L-carnitine and/or vasodilating agents. Additionally, magnesium, electrolytes, fatty acids and hexose sugars can be used. The compositions and methods of this invention are especially beneficial to mammals having reduced energy availability or high energy demand.

Other References

Gross, M., et al., "Ribose administration during exercise: effects on substrates and products of energy metabolism in healthy subjects and a patient with myoadenylate deaminase deficiency", Klinische Wochenshrift, 69 (4), pp. 151-155, (Feb. 26, 1991)
Mahoney, Jr., J.R., et al., "A comparison of different carbohydrates as substrates for the isolated working heart", Journal of Surgical Research, 47 (6), pp. 530-534, (1989)
Pliml, W., et al., "Effects of ribose on exercise-induced ischaemia in stable coronary artery disease", The Lancet, 340 (8818), pp. 507-510, (Aug. 29, 1992)
Schultis, K., et al., "Xylitol in metabolism during stress conditons", Medizin und Ernahrung, 11 (3), Jahrgang, pp. 59-63, (1970)
St. Cyr, J.A., et al., "Enhanced high energy phosphate recovery with ribose infusion after global myocardial ischemia in a canine model", Journal of Surgical Research, 46 (2), pp. 157-162, (Feb. 1989)
Tan, Z.T., et al., "Verapamil,ribose andadenine enhance resynthesis of postischemic myocardial ATP", Life Sciences, 55 (18), pp. PL 345-PL 349, (1994)
Wagner, D.R., et al., "Effects of oral ribose on muscle metabolism during bicycle ergometer in AMPD-deficient patients", Annals of Nutrition and Metabolism, 35 (5), pp. 397-302, (1991)
Zimmer, H.G., et al., "Ribose accelerates the repletion of the ATP pool during recovery from reversible ischemia of the rat myocardium", Journal of Molecular and Cellular Cardiology, 16 (9), pp. 863-866, (Sep. 1984)
Gross, M., et al., "Metabolism of D-Ribose Administered Continuously to Healthy Persons and to Patients with Myoadenylate Deaminase Deficiency", Klin Wochenschr, vol. 67, 1205-1213, (1989)
Tullson, P.C., et al., "Adenine Nucleotide Syntheses in Exercising and Endurance-trained Skeletal Muscle", Doc. No. 0363-5143/91, Copyright 1991, The American Physiological Society, C342-C347, (1991)
Tullson, P.C., et al., "IMP Metabolism in Human Skeletal Muscle After Exhaustive Exercise", Doc. No. 0161-7567/95, Copyright 1995, The American Physiological Society, 146-152, (1995)
Zollner, N., et al., "Myoadenylate Deaminase Deficiency: Successful Symptomatic Therapy by High Dose Oral Administration of Ribose", Klin Wochenschr, vol. 64, 1281-1290, (1986)
Angello, D.A., et al., "Recovery of Myocardial Function and Thallium 201 Redistribution Using Ribose", American Journal of Cardiac Imaging, 3 (4), pp. 256-265, (Dec. 1989